Correlation Between Corvus Pharmaceuticals and XTL Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on Corvus Pharmaceuticals and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and XTL Biopharmaceutica.
Diversification Opportunities for Corvus Pharmaceuticals and XTL Biopharmaceutica
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Corvus and XTL is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and XTL Biopharmaceutica go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and XTL Biopharmaceutica
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 0.83 times more return on investment than XTL Biopharmaceutica. However, Corvus Pharmaceuticals is 1.2 times less risky than XTL Biopharmaceutica. It trades about 0.02 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about -0.18 per unit of risk. If you would invest 910.00 in Corvus Pharmaceuticals on September 2, 2024 and sell it today you would lose (1.00) from holding Corvus Pharmaceuticals or give up 0.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. XTL Biopharmaceuticals Ltd
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| XTL Biopharmaceuticals |
Corvus Pharmaceuticals and XTL Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and XTL Biopharmaceutica
The main advantage of trading using opposite Corvus Pharmaceuticals and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.| Corvus Pharmaceuticals vs. Tff Pharmaceuticals | Corvus Pharmaceuticals vs. Eliem Therapeutics | Corvus Pharmaceuticals vs. Inhibrx | Corvus Pharmaceuticals vs. Enliven Therapeutics |
| XTL Biopharmaceutica vs. Tff Pharmaceuticals | XTL Biopharmaceutica vs. Eliem Therapeutics | XTL Biopharmaceutica vs. Inhibrx | XTL Biopharmaceutica vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |